!
!
Sign in / Join ICS
Home
Efficacy and Tolerability of Fesoterodine in Subjects Stratified by Dose Escalation in an Open-Label Flexible-Dose Study
Morrow J D
1
, Goldfischer E R
2
, Gong J
1
, Tseng L
1
, Guan Z
1
, Wyndaele J J
3
Abstract Category
Pharmacology: Clinical
Abstract 712
Read by Title
Scientific Non Discussion Abstract Session 34
1.
Pfizer Inc, New York, NY, USA,
2.
Hudson Valley Urology, P.C., Poughkeepsie, NY, USA,
3.
Department of Urology, Universiteit en Universitair Ziekenhuis Antwerpen, Antwerp, Belgium
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
24/04/2024 08:02:01